ResMed Inc.
RMD.AXHealthcareASXMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, ResMed Inc. (RMD.AX) is listed under Medical Instruments & Supplies. Valued at $41.70B, RMD.AX is a large-cap name in its sector. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software.
Market Cap
$41.70B
Beta
0.84
P/E (TTM)
19.83
P/E (Fwd)
16.65
EPS (TTM)
$1.45
EPS (Fwd)
$1.73
ROE
25.3%
ROA
14.7%
Cash
$1.66B
Total Debt
$843.2M
Free CF
$1.45B
52W Change
-23.7%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $1.66B in cash comfortably exceeding the $843.2M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $1.45B in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 25.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 14.7% further supports the picture of efficient asset utilization. Revenue has grown from $3.58B (2022) to $5.15B (2025), reflecting a 44% increase over the period.
Investors considering ResMed Inc. should weigh the typical risks associated with RMD.AX's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence ResMed Inc.'s trajectory.